Novel SOURCE study examining development of early COPD in ages 30 to 55
New study aims to provide new insight into how COPD progresses in people with a smoking history
2024-11-14
(Press-News.org) Miami (November 14, 2024) – Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses, according to a new article. The article is published in the September 2024 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open-access journal.
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke and pollution. The disease affects more than 30 million Americans and is the third leading cause of death worldwide.
The multi-year, multicenter study – the SPIROMICS Study of Early Disease Progression (SOURCE) – is focused on enrolling a younger cohort of participants (ages 30 to 55) who have a history of cigarette smoking to help define the mechanisms of COPD progression. The study is examining small airway abnormalities that may lead to emphysema, as well as the possibility of using sputum as a biomarker for COPD.
“Most studies on COPD focus on an older cohort of participants, typically those 60 and older. By enrolling younger participants who are at risk of COPD, we hope to determine why some smokers develop emphysema and some do not,” said Jeffrey L. Curtis, M.D., professor of internal medicine at the University of Michigan Health System’s Division of Pulmonary & Critical Care Medicine, and co-lead author of the study. “This study will allow us to provide novel insight into the progression of the disease, which is necessary for the development of new therapies needed for COPD.”
The SOURCE study uses the existing infrastructure from the large, multi-year SPIROMICS study (SubPopulations and InteRmediate Outcome Measures In COPD Study). Participant data is collected at baseline and at 3-year follow-up visits. Additional information on symptoms, interim health care utilization and exacerbations is collected via phone call every six months.
SOURCE is supported by a grant from the National Institutes of Health’s National Heart, Lung, and Blood Institute and supplemented by contributions made through the COPD Foundation.
To access current and past issues of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, visit journal.copdfoundation.org.
###
About the COPD Foundation
The COPD Foundation is a nonprofit organization whose mission is to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease. The Foundation does this through scientific research, education, advocacy, and awareness to prevent disease, slow progression, and find a cure. For more information, visit copdfoundation.org, or follow us on Twitter and LinkedIn.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-11-14
WASHINGTON – U.S. Naval Research Laboratory (NRL) Naval Center for Space Technology (NCST) in partnership with Defense Advanced Research Projects Agency (DARPA) successfully completed development of a spaceflight qualified robotics suite capable of servicing satellites in orbit, Oct. 8.
Under DARPA funding, NRL developed the Robotic Servicing of Geosynchronous Satellites (RSGS) Integrated Robotic Payload (IRP). This transformative new space capability was delivered to DARPA’s commercial partner, Northrop Grumman’s SpaceLogistics, for ...
2024-11-14
An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms. The study, published in the New England Journal of Medicine, found that treatment with inebilizumab greatly reduced the symptoms of immunoglobulin G4–related disease (IgG4-RD), compared to placebo.
“This is a huge day in the history of this disease,” said lead author John Stone, MD, MPH, a rheumatologist in the Division of Rheumatology, Allergy, and Immunology at Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system. “We are thrilled to have ...
2024-11-14
A new multi-national study has revealed that the shape of the heart is influenced in part by genetics and may help predict the risk of cardiovascular diseases.
Researchers from Queen Mary University of London, King’s College London, University of Zaragoza and University College London, as well as Complexo Hospitalario Universitario A Coruña are first to examine the genetic basis of the heart’s left and right ventricles using advanced 3D imaging and machine learning.
Prior ...
2024-11-14
The world appears to be plagued by crises.
“The financial crisis, the European debt crisis, the migration crisis, the COVID-19 pandemic, the war in Ukraine, the war in Gaza… The world seems to be stumbling from one existential crisis to the next, barely recovering from one before the next one hits,” said Stefan Geiß, a professor from the Department of Sociology and Political Science at the Norwegian University of Science and Technology (NTNU).
However, are there really more crises now than before?
Has it always been this way, or is something new happening? And if there are more public crises today ...
2024-11-14
NEW ORLEANS (November 14, 2024) — A new study from Uganda provides the first evidence to date that resistance to a lifesaving malaria drug may be emerging in the group of patients that accounts for most of the world’s malaria deaths: young African children suffering from serious infections. The study, presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene and published in the Journal of the American Medical Association (JAMA), documented partial resistance to the malaria drug artemisinin in 11 of 100 children, ages 6 months to 12 years, who were being treated for ...
2024-11-14
If you want to seem sincere and receive more responses to your texts, spell out words instead of abbreviating them, according to new research published by the American Psychological Association.
Researchers conducted eight experiments with a total of more than 5,300 participants using various methods. Across the experiments, individuals who used texting abbreviations were perceived as more insincere and were less likely to receive replies because they were seen as exerting less effort in text conversations. The research was published online in the Journal of Experimental Psychology: General.
“In daily interactions, ...
2024-11-14
Highlights:
The Atacama Desert is one of the most extreme habitats on Earth.
Atacama surface soil samples include a mix of DNA from inside and outside living cells.
A new technique allows researchers to separate external and internal DNA to identify microbes colonizing this hostile environment.
This approach for analyzing microbial communities could potentially be applied to other hostile environments, like those on other planets.
Washington, D.C.—The Atacama Desert, which runs along the Pacific Coast in Chile, is the driest place on the planet and, largely because of that aridity, hostile to most living things. ...
2024-11-14
About The Study: This study found artemisinin partial resistance in Ugandan children with complicated malaria associated with the Pfkelch13 A675V variation and also found suboptimal 28-day efficacy of parenteral artesunate followed by oral artemether/lumefantrine therapy.
Corresponding Author: To contact the corresponding author, Chandy C. John, MD, MS, email chjohn@iu.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.22343)
Editor’s Note: Please see the ...
2024-11-14
Sometimes the holes, or pores, in the molecular structure of a chemical only appear in the presence of certain conditions or other ‘guest’ molecules. This affects the field of separation—one of the most important processes in industry—but researchers have only just begun to unravel this phenomenon
Researchers have explored how a particular chemical can selectively trap certain molecules in the cavities of its structure—even though in normal conditions it has no such cavities. This innovative material with now-you-see-them-now-you-don’t holes could lead to more efficient methods for separating ...
2024-11-14
A group of South Korean researchers has successfully developed an integrated quantum circuit chip using photons (light particles). This achievement is expected to enhance the global competitiveness of the team in quantum computation research.
Electronics and Telecommunications Research Institute (ETRI) announced that they have developed a system capable of controlling eight photons using a photonic integrated-circuit chip. With this system, they can explore various quantum phenomena, such as multipartite entanglement resulting from the interaction of the photons.
ETRI’s extensive research on silicon-photonic quantum ...
LAST 30 PRESS RELEASES:
[Press-News.org] Novel SOURCE study examining development of early COPD in ages 30 to 55
New study aims to provide new insight into how COPD progresses in people with a smoking history
